Picking up the Pace: Decreasing Platelet Administration Safely and Effectively

Background Hematology-oncology patients often require blood and blood product transfusions, including platelets (PLTs), to maintain stability. Administering PLTs in a shorter timeframe may prove beneficial by possibly raising platelet counts to a higher level faster, and allowing patients to be disconnected from IV pumps sooner. Objective To evaluate the optimal (safe and effective) transfusion time by comparing standard administration of PLTs over 2–4 h to the investigational administration of PLTs over 30–45 min in the pediatric hematology-oncology inpatient population. Methodology A pilot trial was conducted using a convenience sample of hematology-oncology children. Children prescribed a PLT transfusion while admitted to an inpatient unit were eligible. If randomized to the intervention group, the nurse administered the PLTs over 30–45 min. If randomized to the standard group, the nurse administered the PLTs over 2–4 h. Post transfusion PLTcount was drawn 30 min after completion. The child was monitored closely for adverse reactions. Results Eleven participants were enrolled in the study and 20 PLT infusions administered. No adverse events were noted. There was not a significant difference in changes in PLT counts by group (post minus pre), p = 0.082. There was not a significant difference in post infusion PLT counts, p = 0.727. There was a significant difference in the rate of change in PLT counts by groups, p = 0.003. Nursing implications This pilot study provides preliminary evidence that PLTs may be safely and effectively administered over 30–45 min in pediatric hematology-oncology patients. With quicker PLT administration, patients can be disconnected from IV pumps sooner.